Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20646701 | 0.97 | USP2 (0.42) | USP2LMNAALDH1A1THRBKDM4E | |
| SCHEMBL20637056 | 0.97 | USP2 (0.42) | USP2LMNAALDH1A1THRBKDM4E | |
| SCHEMBL1860602 | 0.90 | USP2 (0.41) | USP2LMNAALDH1A1THRB | |
| SCHEMBL6285648 | 0.90 | USP2 (0.41) | USP2LMNAALDH1A1THRB | |
| SCHEMBL19057791 | 0.89 | USP2 (0.41) | USP2LMNAALDH1A1KDM4ECYP1A2 | |
| SCHEMBL20438573 | 0.89 | USP2 (0.46) | USP2LMNAALDH1A1KDM4ECYP1A2 | |
| SCHEMBL20637053 | 0.86 | USP2 (0.38) | USP2LMNAALDH1A1THRB | |
| SCHEMBL10806924 | 0.86 | USP2 (0.47) | USP2LMNAALDH1A1THRBKDM4E | |
| SCHEMBL10044393 | 0.83 | USP2 (0.44) | USP2LMNAALDH1A1THRBKDM4E | |
| SCHEMBL6258089 | 0.83 | USP2 (0.44) | USP2LMNAALDH1A1THRBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11768436-B2 | Protective film forming composition having a diol structure | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-26 | — | — | US | disclosed |
| US-20230098089-A1 | MULTI-ARM SINGLE MOLECULAR WEIGHT POLYETHYLENE GLYCOL ACTIVE DERIVATIVE AND APPLICATION THEREOF | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2023-03-30 | — | — | US | disclosed |
| US-11518728-B2 | Multi-arm single molecular weight polyethylene glycol, active derivative thereof, and preparation and application thereof | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2022-12-06 | — | — | US | disclosed |
| US-10660969-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2020-05-26 | — | — | US | disclosed |
| US-20200131109-A1 | MULTI-ARM SINGLE MOLECULAR WEIGHT POLYETHYLENE GLYCOL, ACTIVE DERIVATIVE THEREOF, AND PREPARATION AND APPLICATION THEREOF | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2020-04-30 | — | — | US | disclosed |
| US-10434182-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2019-10-08 | — | — | US | disclosed |
| US-20190016856-A1 | MULTI-ARMED POLYETHYLENE GLYCOL AND ACTIVE DERIVATIVE THEREOF | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2019-01-17 | — | — | US | disclosed |
| US-20190016856-A1 | MULTI-ARMED POLYETHYLENE GLYCOL AND ACTIVE DERIVATIVE THEREOF | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2019-01-17 | — | — | US | disclosed |
| US-20180214561-A1 | EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2018-08-02 | — | — | US | disclosed |
| US-20180214561-A1 | EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2018-08-02 | — | — | US | disclosed |
| JP-2003246835-A | NOVEL MULTIFUNCTIONAL EPOXY COMPOUND | NIPPON STEEL CHEM CO LTD | 2003-09-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10434182-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | MRPL38, ALG8, MRPS18A | USP2 2760/4885LMNA 4044/4885ALDH1A1 1103/4885 |
| US-10660969-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | MRPL38, ALG8, COG8 | USP2 2452/4885LMNA 3900/4885ALDH1A1 787/4885 |
| US-20180214561-A1 | EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF | MRPL38, CXCL8, ALG8 | USP2 3075/4885LMNA 3842/4885ALDH1A1 1061/4885 |
| US-20200131109-A1 | MULTI-ARM SINGLE MOLECULAR WEIGHT POLYETHYLENE GLYCOL, ACTIVE DERIVATIVE THEREOF, AND PREPARATION AND APPLICATION THEREOF | VEGFA, MYD88, FCGR2A | USP2 501/4885LMNA 2251/4885ALDH1A1 2056/4885 |
| US-20190016856-A1 | MULTI-ARMED POLYETHYLENE GLYCOL AND ACTIVE DERIVATIVE THEREOF | COG2, PTGER2, MGLL | USP2 212/4885LMNA 1399/4885ALDH1A1 1584/4885 |
| US-20230098089-A1 | MULTI-ARM SINGLE MOLECULAR WEIGHT POLYETHYLENE GLYCOL ACTIVE DERIVATIVE AND APPLICATION THEREOF | FCGR2A, VEGFA, FCGR3B | USP2 393/4885LMNA 2397/4885ALDH1A1 2320/4885 |
| US-11518728-B2 | Multi-arm single molecular weight polyethylene glycol, active derivative thereof, and preparation and application thereof | VEGFA, MYD88, FCGR2A | USP2 501/4885LMNA 2251/4885ALDH1A1 2056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.